Naarden Jacob Van — Insider Trading History & SEC Filings
SEC CIK 1661254 — EVP & Pres., Lilly Oncology
Naarden Jacob Van is a corporate insider tracked via SEC EDGAR filings. Officers, directors, and 10%+ beneficial owners must report transactions in their company's stock on Form 4, typically within two business days. This page shows Naarden Jacob Van's reported transactions, current holdings across companies, and filing history.
Frequently asked questions
Who is Naarden Jacob Van?
Naarden Jacob Van is a corporate insider (SEC CIK 1661254) with reported roles including EVP & Pres., Lilly Oncology. This page tracks their SEC Form 4, Form 3, and Form 5 filings, current holdings, and transaction history.
How current is this insider data?
Insiders must report transactions to the SEC typically within two business days. finshort ingests new EDGAR filings continuously, so transactions appear shortly after they are filed.